Back

A study protocol for an Observational Feasibility Study on Mass Drug Administration and Serology Integrated with Reactive Case Detection for Vivax Malaria Elimination in Cambodia

2026-02-14 public and global health Title + abstract only
View on medRxiv
Show abstract

BackgroundPlasmodium vivax (P. vivax) has emerged as the primary cause of malaria in Cambodia. Achieving malaria elimination and securing malaria-free certification requires a focused effort on addressing P. vivax malaria. This is essential because the elimination of P. vivax often lags behind that of Plasmodium falciparum, making it a critical component in the overall strategy. This study assesses the feasibility of the Mass Drug Administration (MDA) and P. vivax Serological Testing and Treatme...

Predicted journal destinations